Osmotica Pharmaceuticals plc to Provide First Quarter 2020 Business and Financial Update on May 12, 2020
Osmotica Pharmaceuticals (Nasdaq: OSMT) will release its first quarter financial results for 2020 on May 12, 2020, after U.S. markets close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Osmotica Pharmaceuticals (Nasdaq: OSMT) will release its first quarter financial results for 2020 on May 12, 2020, after U.S. markets close. The executive team, including CEO Brian Markison, COO JD Schaub, and CFO Andrew Einhorn, will host a conference call at 4:30 p.m. ET, accessible via toll-free lines and a webcast. The company focuses on developing and commercializing specialty products for underserved patient populations, with operations in the U.S., Argentina, and Hungary.
Positive
- Scheduled financial results release may indicate progress or stability in operations.
- Focus on specialty products could highlight growth potential in underserved markets.
Negative
- None.
Details
News Market Reaction – OSMT
The recorded move for OSMT in the trading session of this news was +0.24%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BRIDGEWATER, N.J., May 08, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, today announced that the Company will release its 2020 first quarter financial results on Tuesday, May 12, 2020, after the close of the U.S. financial markets.
Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call as follows:
| Date Time Toll free (U.S.) International Conference ID Webcast (live and replay) | Tuesday, May 12, 2020 4:30 p.m. ET (866) 672-5029 (409) 217-8312 5646947 www.osmotica.com under the “Investor & News” section | |
About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the non-promoted products including complex generic formulations.
Osmotica has operations in the United States, Argentina, and Hungary.
Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.